GLP-1 reseptor agonist, icyiciro cyimiti yagenewe kwigana ingaruka za glucagon imeze nka peptide-1 (GLP-1 ) , bahinduye uburyo bwo kuvura umubyibuho ukabije n'indwara ya metabolike. GLP-1 isanzwe igira uruhare runini mugutunganya isukari mu maraso no kurya mu gutera insuline no guteza imbere guhaga. Ku bantu bafite umubyibuho ukabije, ubushobozi bwo guhagarika ubushake bwo kurya no gutinda kwa gastrica, hamwe nizindi nyungu za metabolike, bituma imiti ya GLP-1 ari igisubizo cyiza cyo gucunga ibiro birebire. Iyi ngingo iracengera mu miti itandukanye ya GLP-1 yemewe kugabanya ibiro kandi iraganira ku mikorere, umutekano, ndetse n’uburyo bukwiye ku bantu batandukanye.
GLP-1 no Gutakaza ibiro
GLP-1 ni imisemburo ikorwa mu mara irekurwa hasubijwe gufata ibiryo. Igikorwa cyibanze cyayo ni uguhindura urugero rwamaraso glucose mukongera insuline no guhagarika glucagon irekurwa, byombi bifasha kugumana glucose. Ariko, GLP-1 nayo igira uruhare runini mugutunganya ibiro.
Iyo GLP-1 ihuza abayakira mu bwonko, itera ibimenyetso bitera guhaga - bigatuma umuntu yumva yuzuye igihe kirekire. Byongeye kandi, GLP-1 itinda gusiba gastric, ibyo bikagira uruhare mukwiyumvamo kwuzura no kugabanya ubushake bwo kurya. Mugucunga ubushake bwo kurya, GLP-1 mubyukuri ifasha abantu kurya karori nkeya, bigatuma kugabanuka mugihe.
Bitewe n'ingaruka zabyo ku kugaburira ubushake bwo kurya no guhindagura glucose metabolism, GLP-1 reseptor agonist yashyizweho mu rwego rwo kuvura umubyibuho ukabije kandi bigenda byandikirwa ubufasha mu kugabanya ibiro.
Imiti yo hejuru ya GLP-1 yo kugabanya ibiro
Benshi muri GLP-1 reseptor agonist bemejwe kugabanya ibiro, buri kimwe gitandukana mubikorwa byacyo, gahunda ya dosiye, nibisubizo byubuvuzi. Hano hari imiti iganisha kuri iki cyiciro, imaze gutera intambwe igaragara mu kurwanya umubyibuho ukabije hamwe n’ibibazo bijyanye n’ubuzima nka diyabete yo mu bwoko bwa 2.
Semaglutid (Wegovy)
Semaglutid yahise iba imwe mu miti izwi cyane kandi ikora neza ya GLP-1 yo kugabanya ibiro . Yitabiriwe cyane kubera ibimenyetso bifatika byubuvuzi bishyigikira ubushobozi bwayo bwo gufasha abantu guta ibiro neza.
Ibimenyetso bya Clinical : Igeragezwa rya Clinical ryerekanye ko semaglutide (Wegovy) ifite akamaro kanini mu kugabanya ibiro. Mu bigeragezo bya STEP, abarwayi bafashe semaglutide mu byumweru 68 batakaje impuzandengo ya 15% yuburemere bwumubiri, bituma iba imwe mumiti igabanya ibiro iboneka. Uru rwego rwo kugabanya ibiro bifatwa nkigikorwa gikomeye, cyane cyane kubantu bahanganye numubyibuho ukabije. Ku barwayi benshi, gutakaza ijanisha ryinshi ryibiro byumubiri byagaragaye ko bizamura ibimenyetso byubuzima muri rusange, harimo umuvuduko wamaraso, urugero rwisukari rwamaraso, na cholesterol.
Imikoreshereze nuburyo bukoreshwa : Semaglutid itangwa nkinshinge imwe mucyumweru, bigatuma ihitamo abarwayi. Imiti yigana ingaruka za GLP-1 karemano, zongera imisemburo ya insuline, ikabuza glucagon kurekura (imisemburo ishobora kuzamura isukari mu maraso), kandi igabanya ubushake bwo kurya. Byongeye kandi, semaglutide itinda gusiba gastric, ikongerera ibyuzuye bityo bikagabanya ubushake bwo kurya. Ubu buryo butandukanye butuma semaglutide ihitamo neza kubwo kugabanya ibiro no gucunga diyabete.
Kwemeza kuvura umubyibuho ukabije : Semaglutid (Wegovy) yemewe na FDA mu buryo bwihariye bwo kugabanya ibiro ku bantu bafite Indangantego y’umubiri (BMI) ya 30 cyangwa irenga, cyangwa abafite BMI ya 27 cyangwa irenga nabo bafite ubuzima bujyanye n’uburemere nka diyabete yo mu bwoko bwa 2, hypertension, cyangwa cholesterol nyinshi.
Liraglutide (Saxenda)
Liraglutide nubundi buryo bukomeye bwa GLP-1 reseptor agonist yerekanwe gufasha gucunga ibiro . Yize cyane mubigeragezo byamavuriro kandi ni amahitamo azwi kubarwayi bashaka infashanyo yo kugabanya ibiro.
Inyungu n'ibisubizo by'igeragezwa rya Clinical : Ibigeragezo bya SCALE byari ubushakashatsi bwingenzi bwubushakashatsi bwerekana imikorere ya liraglutide mu gucunga ibiro. Muri ibi bigeragezo, abitabiriye gukoresha liraglutide (Saxenda) batakaje impuzandengo ya 5-10% yuburemere bwumubiri. Uru rwego rwo kugabanya ibiro bifatwa nkibyingenzi, cyane cyane kubantu bafite umubyibuho ukabije cyangwa umubyibuho ukabije, kuko no kugabanya ibiro bike bishobora gutera ubuzima bwiza, harimo no kugabanya ibyago byindwara zidakira nkindwara z'umutima na diyabete yo mu bwoko bwa 2.
Mechanism hamwe nibisubizo byabarwayi : Liraglutide ikora kimwe na semaglutide yigana imisemburo isanzwe ya GLP-1. Ifasha guteza imbere gusohora insuline, guhagarika irekurwa rya glucagon, no kongera ibyiyumvo byuzuye, bifasha kugabanya ibiryo. Itandukaniro rigaragara ariko, ni uko liraglutide itangwa hakoreshejwe inshinge ya buri munsi, abarwayi bamwe bashobora kubona ko bitoroshye ugereranije no guterwa inshuro imwe mu cyumweru ya semaglutide. Nubwo bimeze gurtyo, abarwayi benshi bihanganira gahunda ya buri munsi, kandi ibisubizo akenshi bishimangira ubwitange.
Exenatide na Dulaglutide
Mugihe semaglutide na liraglutide byitabiriwe cyane ningaruka zabyo zo kugabanya ibiro, exenatide na dulaglutide nabyo ni umuryango wa GLP-1 wibiyobyabwenge kandi bitanga inyungu zo kugabanya ibiro, nubwo ingaruka zabyo muri rusange zidakabije.
Exenatide (Byetta na Bydureon) : Exenatide yari umwe mubambere ba GLP-1 bakira reseptor agoniste bemewe na diyabete yo mu bwoko bwa 2. Nubwo bidakoreshwa cyane cyane kugabanya ibiro, ubushakashatsi bwamavuriro bwerekanye ko exenatide itanga urugero runaka rwo kugabanya ibiro. Byetta, uburyo bugufi bwo gukora bwa exenatide, butangwa kabiri kumunsi, mugihe Bydureon, verisiyo ndende, ikoreshwa rimwe mubyumweru. Gutera inshuro imwe mu cyumweru ya Bydureon itanga ibyoroshye kandi birashobora gutuma umuntu agabanuka cyane ugereranije no guterwa buri munsi na Byetta.
Dulaglutide (Trulicity) : Dulaglutide, indi GLP-1 yakira reseptor agonist imaze igihe kirekire, yemerewe gukoreshwa muri diyabete yo mu bwoko bwa 2 no gucunga ibiro. Kimwe nabandi GLP-1 reseptor agonist, dulaglutide ifasha kugenzura ubushake bwo kurya no guteza imbere ibyiyumvo byuzuye. Itangwa hakoreshejwe inshinge imwe mucyumweru kandi muri rusange yihanganira abarwayi. Nubwo ingaruka zayo zo kugabanya ibiro zigaragara, zikunda kuba nkeya ugereranije nizigaragara hamwe na semaglutide. Nyamara, kubarwayi bashaka uburyo buciriritse bwo gucunga ibiro, dulaglutide irashobora gutanga inyungu zifatika.
Guhitamo GLP-1 nziza yo kugabanya ibiro
Mugihe uhitamo ibiyobyabwenge bya GLP-1 nibyiza kugabanya ibiro, ibintu byinshi bigomba kwitabwaho:
Amateka yubuvuzi : Abantu bafite amateka ya pancreatite, kanseri ya tiroyide, cyangwa izindi ndwara zimwe na zimwe bagomba kwitonda mugihe bakoresha imiti ya GLP-1. Umuganga wita kubuzima azasuzuma izi ngaruka mugihe atanga inama nziza.
Intego zo kugabanya ibiro : Abantu bamwe bashobora kuba bashaka uburyo bukaze bwo kugabanya ibiro, mugihe abandi bashobora gushaka imiti itanga ibisubizo byoroheje. Urugero, Semaglutid, nuburyo bukomeye kubafite ibibazo byinshi byo kugabanya ibiro, mugihe liraglutide ishobora kuba amahitamo meza kubantu bakunda inshinge za buri munsi no kugabanuka cyane.
Ingaruka zo ku ruhande : Imiti yose ya GLP-1 irashobora gutera ingaruka zo munda nka isesemi, kuruka, no gucibwamo, cyane cyane iyo umubiri ubanza kumenyera imiti. Semaglutid ikunda kwihanganira neza mugihe kirekire ugereranije na liraglutide, ariko reaction yabantu irashobora gutandukana.
Ingaruka nubunararibonye bwabakoresha : Semaglutid ifatwa nkimwe mubikorwa bya GLP-1 byakira reseptor agonist kugirango igabanye ibiro kubera ubushobozi bwayo bwo kugabanya kugabanuka kwibiro byumubiri. Nyamara, ibyifuzo byabarwayi kuri gahunda yo gufata (buri cyumweru na buri munsi) hamwe ningaruka zishobora guterwa mugihe hagomba kubaho imiti yandikirwa.
Umwanzuro
GLP-1 reseptor agonist yerekanye ko ari uburyo bwiza bwo gucunga ibiro kubantu bafite umubyibuho ukabije. Semaglutid (Wegovy) izwi cyane kubushobozi bwayo budasanzwe bwo kugabanya ibiro byinshi, mugihe liraglutide (Saxenda) itanga amahitamo yizewe kubarwayi benshi. Mugihe exenatide na dulaglutide bishobora gutanga ibisubizo biringaniye, biracyafite akamaro kubashaka uburyo bworoheje bwo kugabanya ibiro.
Mugihe uhisemo uburyo bwiza bwo kuvura GLP-1, ni ngombwa ko abarwayi batekereza ku mateka y’ubuvuzi, intego zo kugabanya ibiro, ingaruka mbi, hamwe na gahunda yo guhitamo. Hamwe nubushakashatsi bukomeje gukorwa murwego, biteganijwe ko havuka uburyo bushya kandi bunoze bwo kuvura, butanga ibyiringiro kubantu babarirwa muri za miriyoni barwanya umubyibuho ukabije.
Kubashaka gushakisha ibisubizo bigezweho bishingiye kuri peptide no kurushaho gusobanukirwa uburyo imiti ya GLP-1 ishobora gufasha mugucunga ibiro, Cocer Peptides Co., Ltd itanga ubuyobozi bwinzobere nibicuruzwa byujuje ubuziranenge bijyanye nibyo buri muntu akeneye. Itsinda ryabo rirashobora gufasha hamwe namakuru arambuye kuburyo bwo kuvura no kugufasha gufata icyemezo cyuzuye. Shikira Cocer Peptides Co., Ltd. uyumunsi kugirango ubone inkunga yihariye murugendo rwo kugabanya ibiro.
